Carbonated soft drinks induce oxidative stress and alter the expression of certain genes in the brains of Wistar rats

Molecular Medicine Reports

Volumn 13, Issue 4, 2016, Pages 3147-3154

  El Terras, Adel ^a,b   Soliman, Mohamed Mohamed ^a,c   Alkhedaide, Adel ^a   Attia, Hossam Fouad ^a,c   Alharthy, Abdullah ^a   Banaja, Abdel Elah ^a  

^a TAIF UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

^c Benha University   (Egypt)

Author keywords

Brain activity; Gene expression; Oxidative stress; Soft drinks

Indexed keywords

ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATALASE; DOPAMINE 2 RECEPTOR; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; MESSENGER RNA; SEROTONIN TRANSPORTER; AMINE OXIDASE (FLAVIN CONTAINING); DISCOIDIN DOMAIN RECEPTOR 2;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN FUNCTION; BRAIN HISTOLOGY; BRAIN TISSUE; CARBONATED BEVERAGE; CONTROLLED STUDY; DOWN REGULATION; ELECTROENCEPHALOGRAM; GENE EXPRESSION; HISTOPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT DRINK; WISTAR RAT; ANIMAL; BLOOD; DRUG EFFECTS; GENETICS; MALE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TOXICITY; UPREGULATION;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CARBONATED BEVERAGES; CATALASE; DISCOIDIN DOMAIN RECEPTOR 2; DOWN-REGULATION; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALE; MALONDIALDEHYDE; MONOAMINE OXIDASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84963826933     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.4903     Document Type: Article

References (43)

1. Adjene JO, Ezeoke JC and Nwose EU: Histological effects of chronic consumption of soda pop drinks on kidney of adult Wister rats. N Am J Med Sci 2: 215-217, 2010.
2. Amato D, Maravilla A, García-Contreras F and Paniagua R: Soft-drinks and health. Rev Invest Clin 49: 387-395, 1997.
3. Amato D, Maravilla A, Montoya C, Gaja O, Revilla C, Guerra R and Paniagua R: Acute effects of soft drink intake on calcium and phosphate metabolism in immature and adults rats. Rev Invest Clin 50: 185-189, 1998.
4. Clauson KA, Shields KM, McQueen CE and Persad N: Safety issues associated with commercially available energy drinks. J Am Pharm Assoc (2003) 48: e55-e67, 2008.
5. Iyadurai SJ and Chung SS: New-onset seizures in adults: Possible association with consumption of popular energy drinks. Epilepsy Behav 10: 504-508, 2007.
6. DiMeglio DP and Mattes RD: Liquid versus solid carbohydrate: Effects on food intake and body weight. Int J Obes Relat Metab Disord 24: 794-800, 2000.
7. Mattes RD: Fluid energy-Where's the problem? J Am Diet Assoc 106: 1956-1961, 2006.
8. Frank GK, Oberndorfer TA, Simmons AN, Paulus MP, Fudge JL, Yang TT and Kaye WH: Sucrose activates human taste pathways differently from artificial sweetener. Neuroimage 39: 1559-1569, 2008.
9. Smeets PA, de Graaf C, Stafleu A, van Osch MJ and van der Grond J: Functional magnetic resonance imaging of human hypothalamic responses to sweet taste and calories. Am J Clin Nutr 82: 1011-1016, 2005.
10. Eluwa MA, Inyangmme II, Akpantah AO, Ekanem TB, Ekong MB, Asuquo OR and Nwakanma AA: A comparative study of the effect of diet and soda carbonated drinks on the histology of the cerebellum of adult female albino Wistar rats. Afr Health Sci 13: 541-545, 2013.
11. Soliman MM, Abdo Nassan M and Ismail TA: Immunohistochemical and molecular study on the protective effect of curcumin against hepatic toxicity induced by paracetamol in Wistar rats. BMC Complement Altern Med 14: 457, 2014.
12. Bancroft JD and Gamble M (eds.): Theory and practice of histological techniques. 6th ed. Churchill Livingstone Elsevier Philadelphia: pp126-127, 2008.
13. Ceconi C, Boraso A, Cargnoni A and Ferrari R: Oxidative stress in cardiovascular disease: Myth or fact? Arch Biochem Biophys 420: 217-221, 2003.
14. Moldovan L and Moldovan NI: Oxygen free radicals and redox biology of organelles. Histochem Cell Biol 122: 395-412, 2004.
15. Higgins JP, Tuttle TD and Higgins CL: Energy beverages: Content and safety. Mayo Clin Proc 85: 1033-1041, 2010.
16. Usman A and Jawaid A: Hypertension in a young boy: An energy drink effect. BMC Res Notes 5: 591, 2012.
17. Hotamisligil GS and Breakefield XO: Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49: 383-392, 1991.
18. De Colibus L, Li M, Binda C, Lustig A, Edmondson DE and Mattevi A: Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci USA 102: 12684-12689, 2005.
19. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA and Houle S: Elevated monoamine oxidase a levels in the brain: An explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63: 1209-1216, 2006.
20. Cohen IL, Liu X, Lewis ME, Chudley A, Forster-Gibson C, Gonzalez M, Jenkins EC, Brown WT and Holden JJ: Autism severity is associated with child and maternal MAOA genotypes. Clin Genet 79: 355-362, 2011.
21. Scott AL, Bortolato M, Chen K and Shih JC: Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 19: 739-743, 2008.
22. Vishnivetskaya GB, Skrinskaya JA, Seif I and Popova NK: Effect of MAO A deficiency on different kinds of aggression and social investigation in mice. Aggress Behav 33: 1-6, 2007.
23. Brunner HG, Nelen M, Breakefield XO, Ropers HH and van Oost BA: Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262: 578-580, 1993.
24. Mohapel P, Leanza G, Kokaia M and Lindvall O: Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol Aging 26: 939-946, 2005.
25. Oda Y: Choline acetyltransferase: The structure, distribution and pathologic changes in the central nervous system. Pathol Int 49: 921-937, 1999.
26. Lam KS, Aman MG and Arnold LE: Neurochemical correlates of autistic disorder: A review of the literature. Res Dev Disabil 27: 254-289, 2006.
27. Eckenstein F and Sofroniew MV: Identification of central cholinergic neurons containing both choline acetyltransferase and acetylcholinesterase and of central neurons containing only acetylcholinesterase. J Neurosci 3: 2286-2291, 1983.
28. Shytle RD, Silver AA, Lukas RJ, Newman MB, Sheehan DV and Sanberg PR: Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry 7: 525-535, 2002.
29. Glazer WM and Dickson RA: Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 59 (Suppl 3): 8-14, 1998.
30. Miczek KA, Covington HE III, Nikulina EM Jr and Hammer RP: Aggression and defeat: Persistent effects on cocaine self-administration and gene expression in peptidergic and aminergic mesocorticolimbic circuits. Neurosci Biobehav Rev 27: 787-802, 2004.
31. de Almeida RM, Ferrari PF, Parmigiani S and Miczek KA: Escalated aggressive behavior: Dopamine, serotonin and GABA. Eur J Pharmacol 526: 51-64, 2005.
32. Ferrari PF, van Erp AM, Tornatzky W and Miczek KA: Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 17: 371-378, 2003.
33. Ferrari PF, Palanza P, Parmigiani S, de Almeida RM and Miczek KA: Serotonin and aggressive behavior in rodents and nonhuman primates: Predispositions and plasticity. Eur J Pharmacol 526: 259-273, 2005.
34. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D and Karayiorgou M: Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95: 9991-9996, 1998.
35. Chiavegatto S and Nelson RJ: Interaction of nitric oxide and serotonin in aggressive behavior. Horm Behav 44: 233-241, 2003.
36. Coccaro EF and Kavoussi RJ: Neuropsychopharmacologic challenge in biological psychiatry. Clin Chem 40: 319-327, 1994.
37. Barkan T, Peled A, Modai I, Barak P, Weizman A and Rehavi M: Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients. Eur Neuropsychopharmacol 16: 572-579, 2006.
38. Blader JC: Pharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behavior. J Clin Psychopharmacol 26: 419-425, 2006.
39. Bond AJ: Antidepressant treatments and human aggression. Eur J Pharmacol 526: 218-225, 2005.
40. Carrillo M, Ricci LA, Coppersmith GA and Melloni RH Jr: The effect of increased serotonergic neurotransmission on aggression: A critical meta-analytical review of preclinical studies. Psychopharmacology (Berl) 205: 349-368, 2009.
41. Caldwell EE and Miczek KA: Long-term citalopram maintenance in mice: Selective reduction of alcohol-heightened aggression. Psychopharmacology (Berl) 196: 407-416, 2008.
42. Deutch AY and Roth RH: Neurotransmitters In: Fundamental Neuroscience. Squire L, Berg S, Bloom F, du Lac S, Ghosh A and Spitzer N (eds). 3rd edition. Elsevier/Academic Press, Amsterdam, pp143, 2008.
43. Holmes A, Murphy DL and Crawley JN: Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161: 160-167, 2002.